Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 5
2004 3
2005 4
2006 4
2007 8
2008 7
2009 5
2010 12
2011 12
2012 9
2013 5
2014 5
2015 6
2016 4
2017 8
2018 6
2019 9
2020 17
2021 22
2022 13
2023 9
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Results by year

Filters applied: . Clear all
Page 1
Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: results from an expansion cohort of a multicentre, open-label, phase 1b trial (COSMIC-021).
Agarwal N, McGregor B, Maughan BL, Dorff TB, Kelly W, Fang B, McKay RR, Singh P, Pagliaro L, Dreicer R, Srinivas S, Loriot Y, Vaishampayan U, Goel S, Curran D, Panneerselvam A, Schwickart M, Choueiri TK, Pal S. Agarwal N, et al. Among authors: goel s. Lancet Oncol. 2022 Jul;23(7):899-909. doi: 10.1016/S1470-2045(22)00278-9. Epub 2022 Jun 9. Lancet Oncol. 2022. PMID: 35690072 Clinical Trial.
Immunotherapeutic advances in gastrointestinal malignancies.
Rao D, Parakrama R, Augustine T, Liu Q, Goel S, Maitra R. Rao D, et al. Among authors: goel s. NPJ Precis Oncol. 2019 Feb 5;3:4. doi: 10.1038/s41698-018-0076-8. eCollection 2019. NPJ Precis Oncol. 2019. PMID: 30729176 Free PMC article. Review.
Eribulin in Cancer Treatment.
Swami U, Shah U, Goel S. Swami U, et al. Among authors: goel s. Mar Drugs. 2015 Aug 7;13(8):5016-58. doi: 10.3390/md13085016. Mar Drugs. 2015. PMID: 26262627 Free PMC article. Review.
Patterns of Response and Progression to Immunotherapy.
Borcoman E, Nandikolla A, Long G, Goel S, Le Tourneau C. Borcoman E, et al. Among authors: goel s. Am Soc Clin Oncol Educ Book. 2018 May 23;38:169-178. doi: 10.1200/EDBK_200643. Am Soc Clin Oncol Educ Book. 2018. PMID: 30231380 Free article. Review.
Phase 1 dose-escalation study of SEA-CD40: a non-fucosylated CD40 agonist, in advanced solid tumors and lymphomas.
Coveler AL, Smith DC, Phillips T, Curti BD, Goel S, Mehta AN, Kuzel TM, Markovic SN, Rixe O, Bajor DL, Gajewski TF, Gutierrez M, Lee HJ, Gopal AK, Caimi P, Heath EI, Thompson JA, Ansari S, Jacquemont C, Topletz-Erickson A, Zhou P, Schmitt MW, Grilley-Olson JE. Coveler AL, et al. Among authors: goel s. J Immunother Cancer. 2023 Jun;11(6):e005584. doi: 10.1136/jitc-2022-005584. J Immunother Cancer. 2023. PMID: 37385724 Free PMC article. Clinical Trial.
Therapeutic Targets of KRAS in Colorectal Cancer.
Rahman S, Garrel S, Gerber M, Maitra R, Goel S. Rahman S, et al. Among authors: goel s. Cancers (Basel). 2021 Dec 11;13(24):6233. doi: 10.3390/cancers13246233. Cancers (Basel). 2021. PMID: 34944853 Free PMC article. Review.
K-Ras, intestinal homeostasis and colon cancer.
Goel S, Huang J, Klampfer L. Goel S, et al. Curr Clin Pharmacol. 2015;10(1):73-81. doi: 10.2174/1574884708666131111204440. Curr Clin Pharmacol. 2015. PMID: 24219000 Review.
155 results